comprehensive -WSS

comprehensive

author：leisure time 2025-09-28 23:47:10 - browse：6661

A man enters the Regeneron Clinic at a monoclonal antibody treatment site in Pembroke Pines, Florida – politics and policy coverage from STAT — Regeneron agreed to price limits for a new Covid-19 drug that will be developed in partnership with the Department of Health and Human Services. CHANDAN KHANNA/AFP via Getty Images

WASHINGTON — A groundbreaking clause in a new deal between the Department of Health and Human Services and the pharmaceutical company Regeneron marks the first time the Biden administration has directly used its leverage to challenge drugmakers’ list prices, experts told STAT.

The contract between Regeneron and the government requires that the list price for a future monoclonal antibody drug to prevent Covid-19 is the same or lower in the United States as in other high-income countries. The release doesn’t explain which countries the government will be comparing prices with, or how pricing data will be determined.

The deal was part of the White House’s Project NextGen initiative, which includes $5 billion in new vaccines and therapies. HHS announced that it is spending $326 million to help Regeneron develop a new monoclonal antibody to prevent Covid-19. Regeneron in January announced plans to start testing a potentially variant-proof antibody, which is set to go into clinical trials later this year.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Rune Labs, whose app tracks Parkinson's symptoms, raises $12M

Wikipedia

knowledge

WSS

Do masks work? RCTs can't tell us

New guidelines on severe brain injury complicate already difficult decisions

With FDA staff opposed to Sarepta therapy, top official intervened

JPM 2024: Biotech’s most prolific dealmaker sees a rosy 2024

Hospital chaplains balance Covid safety with patients’ spiritual needs

New guidelines on severe brain injury complicate already difficult decisions

leisure time

comprehensive

Wikipedia

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

CDC concerned about possible undetected monkeypox spread in U.K.

Duchenne breakthrough therapy leaves behind pioneering families

Mayo Clinic partners with supercomputer AI firm Cerebras at JPM

Virginia high school admissions case could be legal follow

Obesity experts on risks of Wegovy, Ozempic weight loss drugs

Medical leaders decry Supreme Court decision on affirmative action

Male doctors called my cancer incurable. A female doctor showed it wasn't

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

JPM pitch from hospitals? Revenue streams outside of patient care

explore

FDA grants conditional OK to Sarepta’s gene therapy for Duchenne

Readout Newsletter: Cytokinetics and Novartis' starcrossed tale

Stories you might have missed in 2023: health, science, medicine

Fauci's latest grilling in Congress: 9 hours, behind closed doors

Stories you might have missed in 2023: health, science, medicine

The story of mRNA: From a loose idea to a tool that may help curb Covid

Wikipedia

Wikipedia

knowledge

focus